iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy

被引:0
|
作者
Hongmei Lu
Shaodong Deng
Minghui Zheng
Kunhua Hu
机构
[1] Guangdong Medical University,The Second Clinical Medical College
[2] Sun Yat-sen Memorial Hospital of Sun Yat-sen University,Department of Clinical Laboratory
[3] Sun Yat-sen University,Proteomics Center, Zhongshan School of Medicine
来源
Clinical Proteomics | 2019年 / 16卷
关键词
Incipient diabetic nephropathy; Biomarker; iTRAQ;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy
    Piwowar, Agnieszka
    Knapik-Kordecka, Maria
    Szczecinska, Joanna
    Warwas, Maria
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 (07) : 549 - 553
  • [42] Incipient to overt: Angiotensin II blocker, telmisartan, investigation on type 2 diabetic nephropathy (INNOVATION) study
    Makino, Hirofumi
    Haneda, Masakazu
    Babazono, Tetsuya
    Moriya, Tatsumi
    Ito, Sadayoshi
    Iwamoto, Yasuhiko
    Kawamori, Ryuzo
    Takeuchi, Masahiro
    Katayama, Shigehiro
    JOURNAL OF HYPERTENSION, 2006, 24 : 31 - 31
  • [43] Identification of Serum Biomarkers for Ischemic Penumbra by iTRAQ-Based Quantitative Proteomics Analysis
    Pang, Xiao-Min
    Zhou, Xia
    Su, Sheng-You
    Chen, Chun-Yong
    Wei, Zhi-Xiao
    Tao, Yi-Feng
    Liu, Jing-Li
    PROTEOMICS CLINICAL APPLICATIONS, 2019, 13 (05)
  • [44] Preliminary proteomics analysis for sepsis biomarkers with iTRAQ labeling and LC-MS/MS
    Su, Longxiang
    Zhou, Ruo
    Cao, Lichao
    Xiao, Kun
    Wen, Bo
    Xie, Lixin
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [45] iTRAQ-Based Proteomics Analysis of Serum Proteins in Wistar Rats Treated with Sodium Fluoride: Insight into the Potential Mechanism and Candidate Biomarkers of Fluorosis
    Wei, Yan
    Zeng, Beibei
    Zhang, Hua
    Chen, Cheng
    Wu, Yanli
    Wang, Nanlan
    Wu, Yanqiu
    Shen, Liming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (10):
  • [46] Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
    Darmayanti, Siska
    Lesmana, Ronny
    Meiliana, Anna
    Abdulah, Rizky
    CURRENT DIABETES REVIEWS, 2021, 17 (06)
  • [47] Pursuing Diabetic Nephropathy through Aqueous Humor Proteomics Analysis
    Chen, Huan
    Wang, Tan
    Wang, Erqian
    Li, Ningning
    Min, Hanyi
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [48] Adiponectin gene polymorphism (G276T) is not associated with incipient diabetic nephropathy in Japanese type 2 diabetic patients
    Yoshioka, K
    Yoshida, T
    Umekawa, T
    Kogure, A
    Takakura, Y
    Toda, H
    Yoshikawa, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (09): : 1223 - 1226
  • [49] Urinary matrix metalloproteinase-8 and-9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy?
    van der Zijl, Nynke J.
    Hanemaaijer, Land
    Tushuizen, Maarten E.
    Schindhelm, Roger K.
    Boerop, Jeannette
    Rustemeijer, Cees
    Bilo, Henk J.
    Verheijen, Jan H.
    Diamant, Michaela
    CLINICAL BIOCHEMISTRY, 2010, 43 (7-8) : 635 - 639
  • [50] Long-term effect of epalrestat, an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in Type 2 diabetic patients
    Iso, K
    Tada, H
    Kuboki, K
    Inokuchi, T
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (05) : 241 - 244